Kirkwood, MO, United States of America

Maksym Artomov

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Maksym Artomov in Cancer Therapy

Introduction

Maksym Artomov is an accomplished inventor based in Kirkwood, MO, who has made significant contributions to the field of cancer therapy. With a total of three patents to his name, he is dedicated to advancing medical treatments through innovative approaches.

Latest Patents

Maksym's latest patents include groundbreaking work on a therapeutic cancer vaccine library. This patent focuses on constructing and utilizing fusion-specific vaccines tailored for cancer patients. The methods described involve selecting a therapeutic vaccine from a library or creating a new vaccine for patients with specific gene fusions. Another notable patent addresses the administration of checkpoint blockade therapy. This method involves analyzing gene expression data to predict a subject's response to immune checkpoint blockade therapy, utilizing a statistical model trained on extensive expression data.

Career Highlights

Maksym Artomov is currently employed at Bostongene Corporation, where he continues to push the boundaries of cancer research and treatment. His work is characterized by a commitment to improving patient outcomes through innovative therapeutic strategies.

Collaborations

Maksym collaborates with talented individuals such as Feliks Frenkel and Nikita Kotlov, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Maksym Artomov's contributions to cancer therapy through his patents and work at Bostongene Corporation highlight his dedication to improving medical treatments. His innovative approaches are paving the way for advancements in cancer care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…